BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 17686873)

  • 1. Promoter complex in the central part of the mouse mammary tumor virus long terminal repeat.
    Rouault F; Nejad Asl SB; Rungaldier S; Fuchs E; Salmons B; Günzburg WH
    J Virol; 2007 Nov; 81(22):12572-81. PubMed ID: 17686873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous superantigen expression controlled by a novel promoter in the MMTV long terminal repeat.
    Günzburg WH; Heinemann F; Wintersperger S; Miethke T; Wagner H; Erfle V; Salmons B
    Nature; 1993 Jul; 364(6433):154-8. PubMed ID: 8391646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of a MMTV/mdr3 fusion transcript from a cryptic viral promoter is stimulated by mdr-derived sequences located in intron I.
    Lepage P; Underhill DA; Gros P
    Virology; 1995 Jul; 210(2):244-53. PubMed ID: 7618265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Control of endogenous mouse mammary tumor virus superantigen expression in SJL lymphomas by a promoter within the env region.
    Zhang DJ; Tsiagbe VK; Huang C; Thorbecke GJ
    J Immunol; 1996 Oct; 157(8):3510-7. PubMed ID: 8871650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abundant authentic MMTV-Env production from a recombinant provirus lacking the major LTR promoter.
    Rungaldier S; Nejad Asl SB; Günzburg WH; Salmons B; Rouault F
    Virology; 2005 Nov; 342(2):201-14. PubMed ID: 16140354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular events in B lymphocyte differentiation. Inducible expression of the endogenous mouse mammary tumor proviral gene, Mtv-9.
    King LB; Lund FE; White DA; Sharma S; Corley RB
    J Immunol; 1990 Apr; 144(8):3218-27. PubMed ID: 2157765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A redundant nuclear protein binding site contributes to negative regulation of the mouse mammary tumor virus long terminal repeat.
    Bramblett D; Hsu CL; Lozano M; Earnest K; Fabritius C; Dudley J
    J Virol; 1995 Dec; 69(12):7868-76. PubMed ID: 7494299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mouse mammary tumor virus superantigen expression is reduced by glucocorticoid treatment.
    Tovar Sepúlveda VA; Berdel B; Coffin JM; Reuss FU
    Virology; 2000 Sep; 275(1):98-106. PubMed ID: 11017791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequence similarity between the long terminal repeat coding regions of mammary-tumorigenic BALB/cV and renal-tumorigenic C3H-K strains of mouse mammary tumor virus.
    Kang JJ; Schwegel T; Knepper JE
    Virology; 1993 Sep; 196(1):303-8. PubMed ID: 8395120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strain-specific expression of spliced MMTV RNAs containing the superantigen gene.
    Xu L; Wrona TJ; Dudley JP
    Virology; 1997 Sep; 236(1):54-65. PubMed ID: 9299617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FoxA1 binding to the MMTV LTR modulates chromatin structure and transcription.
    Holmqvist PH; Belikov S; Zaret KS; Wrange O
    Exp Cell Res; 2005 Apr; 304(2):593-603. PubMed ID: 15748903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mouse mammary tumor proviral gene expression in cells of the B lineage.
    Corley RB; Lund FE; Randall TD; King LB; Doerre S; Woodland DL
    Semin Immunol; 1992 Oct; 4(5):287-96. PubMed ID: 1336679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CDP binding to multiple sites in the mouse mammary tumor virus long terminal repeat suppresses basal and glucocorticoid-induced transcription.
    Zhu Q; Dudley JP
    J Virol; 2002 Mar; 76(5):2168-79. PubMed ID: 11836394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a protein that recognizes a distal negative regulatory element within the mouse mammary tumor virus long terminal repeat.
    Kang CJ; Peterson DO
    Virology; 1999 Nov; 264(1):211-9. PubMed ID: 10544147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phylogenetic and structural analyses of MMTV LTR ORF sequences of exogenous and endogenous origins.
    Brandt-Carlson C; Butel JS; Wheeler D
    Virology; 1993 Mar; 193(1):171-85. PubMed ID: 8382394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro analysis of transcriptional repression of the mouse mammary tumor virus promoter.
    Kang CJ; Peterson DO
    Biochem Biophys Res Commun; 2001 Sep; 287(2):402-10. PubMed ID: 11554742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection and characterization of a glycoprotein encoded by the mouse mammary tumor virus long terminal repeat gene.
    Brandt-Carlson C; Butel JS
    J Virol; 1991 Nov; 65(11):6051-60. PubMed ID: 1656086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo binding of proteins to stably integrated MMTV DNA in murine cell lines: occupancy of NFI and OTF1 binding sites in the absence and presence of glucocorticoids.
    Härtig E; Cato AC
    Cell Mol Biol Res; 1994; 40(7-8):643-52. PubMed ID: 7787882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The long terminal repeat region of the mouse mammary tumour virus contains multiple regulatory elements.
    Mink S; Ponta H; Cato AC
    Nucleic Acids Res; 1990 Apr; 18(8):2017-24. PubMed ID: 2159634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of cAMP on reporter bioassays for dioxin and dioxin-like compounds.
    Kasai A; Yao J; Yamauchi K; Hiramatsu N; Hayakawa K; Meng Y; Maeda S; Kitamura M
    Toxicol Appl Pharmacol; 2006 Feb; 211(1):11-9. PubMed ID: 15972221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.